Joan Magoba Nyangoma
ID:
|
The Self Representation of Community Foundations in Uganda as Community Leaders
REFNo: SS1113ES
The study seeks to identify Community Foundations in Kampala City and Wakiso District to understand among others; how they define themselves, how they operate, and their role in the communities they serve. Specifically, the study seeks to answer the following questions:
i. Which CFs exists in Kampala and Wakiso?
ii. How do CFs in Kampala and Wakiso operate?
a. How do they define themselves?
b. Who are their benefactors/members?
c. Are they active (have a base/focal point for their operations, implementing activities including meetings, fundraising, disbursing grants?
 Do they keep clear records of members contributions, membership records, expenditures, receipts, etc.?
 Do they have a clear leadership structure and how do they choose their leaders, implementing activities?
d. How do they support their projects/Work or raise their funds?
e. What is the level of awareness of CFs in the communities they serve (are they known, are they online, are they registered with local authorities)?
iii. What are the roles of CFs in Kampala and Wakiso?
a. What are the visions, missions, goals and objects of the CFs?
b. What activities do they implement in pursuance of their objectives?
c. Who are the beneficiaries?
iv. What is the impact of these CFs?
a. What are their successes?
b. What challenges are they faced with?
c. How can these challenges be overcome or alleviated?
d. Are these based on their transactional/transformative identity?
|
Uganda |
2021-12-22 |
2024-12-22 |
Social Science and Humanities |
Non-Clinical Trial |
Non-degree Award |
|
NICHOLAS KULABA
ID:
|
Blood Pressure Variability and Early Clinical Outcomes Amongst Stroke Patients Admitted to Mbarara Regional Referral Hospital
REFNo: HS1973ES
2. To determine the association between blood pressure variability and poor clinical outcome measured by modified Rankin score at fourteen days after a stroke onset.,1. To determine variability in systolic blood pressure and diastolic blood pressure that occurs over seven days in both hemorrhagic and ischemic stroke patients after hospitalization,To determine blood pressure variability and its association with early clinical outcome amongst acute and subacute stroke patients admitted within 7 days onset at MRRH.,
|
Uganda |
2021-12-21 |
2024-12-21 |
Medical and Health Sciences |
Non-Clinical Trial |
Degree Award |
|
David Musoke
ID:
|
A Health Systems Approach to Strengthening Community Health in Wakiso District, Uganda
REFNo: HS1965ES
The project is aimed at strengthening community health using a health systems approach with a focus on: (a) enhancing the capacity of CHWs (locally known as village health teams (VHTs)), their coordinators and supervisors; (b) supporting the completeness and timely submission of data from VHTs; (c) enhancing timely delivery of drugs and other commodities to CHWs; (e) improving performance of CHWs in relation to quality of care, respective care, and timely referral of patients; and (f) supporting the supervision and coordination of community health.
|
Uganda |
2021-12-21 |
2024-12-21 |
Medical and Health Sciences |
Non-Clinical Trial |
Non-degree Award |
|
Victoria Nankabirwa
ID: UNCST-2021-R011871
|
Effectiveness of mobile money payments to vaccination campaign health care workers on polio vaccination campaign coverage and quality: a cluster randomized controlled trial
REFNo: HS1932ES
Primary Objectives:
1) To compare vaccination coverage in areas where campaign health care workers are paid using mobile money versus in cash.
2) To compare the motivation, satisfaction and performance of vaccination health care workers in areas where they are paid using mobile money versus in cash
Secondary objectives:
1) To compare vaccination campaign quality in areas where health care workers are paid using mobile money versus in cash
2) To estimate the incremental cost of the intervention.
|
Uganda |
2021-12-20 |
2024-12-20 |
Medical and Health Sciences |
Non-Clinical Trial |
Non-degree Award |
.jpg)
|
SSEMBATYA RENNY
ID:
|
COVID/COPE Study: An Interdisciplinary Empirical Approach to Understanding Unequal Economic and Health Consequences of COVID-19 Measures among Pregnant Women in Uganda
REFNo: SS936ES
Objective 1: To analyze the effects of Covid-19 measures among pregnant women in Uganda of varying size, socio-economic, health and poverty indexes.
Objective 2: To assess the proportion of pregnant women with symptoms, rates of social interactions; financial and non-financial costs; how pregnant women have recently responded to the Covid-19 measures, especially in relation to their personal circumstances and expectations.
Objective 3: To provide recommendations how to improve access to care for these vulnerable populations and prevent unnecessary, delayed care while safeguarding public health concerns.
|
Uganda |
2021-12-17 |
2024-12-17 |
Social Science and Humanities |
Non-Clinical Trial |
Non-degree Award |
|
Obondo Sande James
ID: UNCST-2019-R000241
|
Capacity Building towards Primary Immunodeficiency Disorders Research, Diagnosis, and Clinical Management in Uganda
REFNo: HS1867ES
3. To strengthen local laboratory screening and research capacity in the management of PIDs. ,2. To increase knowledge on PIDs among clinicians, pediatricians, laboratory technologists, immunologists through training focused on detection of potential PIDs cases. ,1. To map and create profiles of the current PIDs knowledge and diagnostic capacity in Uganda,To evaluate clinical and laboratory diagnostic knowledge about PIDs, and undertake PIDs-focused training in Uganda,
|
Uganda |
2021-12-17 |
2024-12-17 |
Medical and Health Sciences |
Non-Clinical Trial |
Non-degree Award |
|
Claudia Ringler
ID:
|
Endline Evaluation for Reaching Smallholder Women with Information Services and Resilience Strategies to Respond to Climate Change
REFNo: SS1127ES
3) At the endline (The subject of this application, to be undertaken in January of 2022), the study will establish the impact of the strategies used to disseminate the climate-smart technologies and approaches and whether these translate into closing gendered yield gaps, enhanced equity and inclusion.
|
Germany |
2021-12-17 |
2024-12-17 |
Social Science and Humanities |
Non-Clinical Trial |
Non-degree Award |
|
Victoria Ndyanabangi
ID: UNCST-2021-R012645
|
Pharmacokinetic Properties of Antiretroviral and Anti-Tuberculosis Drugs during Pregnancy and Postpartum,DAIDS Study ID #38609,
IND #146262
REFNo: HS1023ES
Primary Objectives
Component 1:
• To describe the PK parameters during pregnancy of selected ARV drugs administered to WLHIV who are not receiving TB drugs, and to compare these parameters to (a) historical PK data from non-pregnant women and (b) each participant’s own postpartum PK data.
Component 2:
• To describe the kinetics of (a) placental and breast milk transfer of CAB LA from mother to fetus/infant and (b) infant elimination of CAB LA acquired across the placenta after maternal dosing during pregnancy.
Component 3:
• To describe the PK parameters during pregnancy and postpartum of selected ARV drugs and first-line TB treatment drugs co-administered to WLHIV.
Component 4:
• To describe the PK parameters during pregnancy and postpartum of second-line TB treatment drugs administered to WLHIV and HIV-uninfected women.
Component 5:
• To describe the kinetics of drug transfer of selected ARVs from mother to infant via breast milk.
Secondary Objectives
All Components:
• To describe maternal and infant safety and clinical outcomes.
Components 1, 3 and 4:
• To compare drug concentrations in plasma from cord blood with concentrations in maternal plasma at delivery for selected ARV and/or TB treatment drugs.
• To describe the neonatal elimination of selected ARV and/or TB treatment drugs acquired across the placenta after maternal dosing during pregnancy.
Components 3 and 4:
• To describe the kinetics of drug transfer of selected ARVs and/or TB treatment drugs from mother to infant via breast milk
Component 4:
• To describe the PK parameters of selected ARVs when co-administered with selected second-line TB treatment drugs to WLHIV during pregnancy and postpartum.
Other Objectives
• To assess plasma protein binding of highly bound ARVs and/or TB treatment drugs during pregnancy and postpartum.
• To explore genetic sources for variability in drug exposure in pregnant and postpartum women and their infants for selected ARV and/or TB treatment drugs.
|
Uganda |
2021-12-16 |
2024-12-16 |
Medical and Health Sciences |
|
Non-degree Award |
|
Katrina Fernandez
ID:
|
Determining distribution, ecology and threats of otter species in Uganda
REFNo: NS245ES
1)To confirm the presence of otter species in and around specific wetlands in Uganda.
2)Determine the ecology, habitat, behaviour and threats to otter species in Uganda.
3)Generate awareness and education to create stewardship and foster positivity towards wildlife and habitats.
4)Identifying conflict issues and threats and developing mitigation measures where necessary.
|
India |
2021-12-16 |
2024-12-16 |
Natural Sciences |
Non-Clinical Trial |
Non-degree Award |
|
BOSCO AGABA BEKIITA
ID: UNCST-2019-R000549
|
Protocol for Regional Estimation of pfhrp2/3 gene deletion in P. falciparum parasites in Uganda (Prep)
REFNo: HS1911ES
1. Estimate the proportion of P. falciparum pfhrp2/3 gene deletions among false-negative HRP2 RDTs in the regions
2. Detect the parasite density and frequency of non-P. falciparum species in the samples
3. Identify regions in which the prevalence of pfhrp2/3 gene deletions causing false negative P. falciparum RDTs is at or above 5%, warranting a change in RDTs.
4. Assess the diagnostic field performance of the HRP2 and pan-pLDH RDTs compared to PCR as gold standard
|
Uganda |
2021-12-16 |
2024-12-16 |
Medical and Health Sciences |
Non-Clinical Trial |
Non-degree Award |
|
| View |
|
Sort By: |
|
|
|
| |
|